Use of conservative management for low-risk prostate cancer ‘increasing rapidly'
3 monthes ago - By Healio
Conservative management or deferred treatment is the preferred approach for men with low-risk prostate cancer, according to results of a large VA cohort study.
Stacy Loeb, MD, assistant professor of urology and population health at NYU Langone Health and the Manhattan VA, and colleagues assessed utilization of conservative management in a cohort of 125,083 veterans newly diagnosed with prostate cancer between 2005 and 2015.
In 2005, 27% of men aged 65 years or younger chose to postpone immediate therapy and 4% elected to be managed with active surveillance. In 2015, 75% chose to
Read more ...
The headlines of Master Doctor
Blasting prostate tumours with radiotherapy CAN increase the chances of survival
Targeting the source of advanced prostate cancer with radiotherapy after the disease has spread could increase the patient's chances of survival by 11 per cent.
Cranberry extract prevents Alzheimer's
Cranberry juice, which is full of antioxidants, demonstrates various health benefits and it is often used to prevent age-related brain decline. According to a study, cranberry...
Chronic Inflammation Linked to Increased Alzheimer's Disease Risk
ApoE4 gene carriers who have chronic inflammation are more likely to develop Alzheimer's disease, finds a new study.
Brain's connection to immune system discovered: New study identifies...
“We literally watched people's brains drain fluid into these vessels,” said Daniel S. Reich, senior investigator at the National Institutes of Health , as he was asked to...
Patient-reported data confirms efficacy of brachytherapy alone in...
Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy to transperineal interstitial permanent brachytherapy alone indicate a...
Nearly 90% Free of Prostate Ca Progression With ADT, Pelvic Node RT
Data also showed trend toward reduction in distant metastases
Prostate RT Ups Overall Survival in Metastatic Disease
Benefit limited to men with low disease burden
Biomarker May Distinguish Parkinson's From MSA
Alpha-synuclein in brain-derived blood exosomes is a potential biomarker that allows Parkinson's disease to be more easily distinguished from multiple system atrophy . Medscape...
Scientists create genetic score that predicts lifespan
New research uncovers 21 genetic variants that are associated with changes in lifespan and presents a genetic score that predicts a person's survival.
Losing control of gene activity in Alzheimer's disease
Pioneering research into the mechanisms controlling gene activity in the brain could hold the key to understanding Alzheimer's disease and might help identify effective...